JP2015501834A5 - - Google Patents

Download PDF

Info

Publication number
JP2015501834A5
JP2015501834A5 JP2014546717A JP2014546717A JP2015501834A5 JP 2015501834 A5 JP2015501834 A5 JP 2015501834A5 JP 2014546717 A JP2014546717 A JP 2014546717A JP 2014546717 A JP2014546717 A JP 2014546717A JP 2015501834 A5 JP2015501834 A5 JP 2015501834A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
seq
drug
subarachnoid hemorrhage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014546717A
Other languages
English (en)
Japanese (ja)
Other versions
JP6279483B2 (ja
JP2015501834A (ja
Filing date
Publication date
Priority claimed from CA2762338A external-priority patent/CA2762338C/en
Application filed filed Critical
Priority claimed from PCT/IB2012/057259 external-priority patent/WO2013088382A1/en
Publication of JP2015501834A publication Critical patent/JP2015501834A/ja
Publication of JP2015501834A5 publication Critical patent/JP2015501834A5/ja
Application granted granted Critical
Publication of JP6279483B2 publication Critical patent/JP6279483B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014546717A 2011-12-13 2012-12-13 くも膜下出血および虚血の治療法 Expired - Fee Related JP6279483B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201161570264P 2011-12-13 2011-12-13
US61/570,264 2011-12-13
CA2762338A CA2762338C (en) 2011-12-13 2011-12-15 Therapy for subarachnoid hemorrhage and ischemia
CA2,762,338 2011-12-15
US201261617001P 2012-03-28 2012-03-28
US61/617,001 2012-03-28
PCT/IB2012/057259 WO2013088382A1 (en) 2011-12-13 2012-12-13 Therapy for subarachnoid hemorrhage and ischemia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017217549A Division JP6741642B2 (ja) 2011-12-13 2017-11-10 くも膜下出血および虚血の治療法

Publications (3)

Publication Number Publication Date
JP2015501834A JP2015501834A (ja) 2015-01-19
JP2015501834A5 true JP2015501834A5 (enExample) 2016-02-04
JP6279483B2 JP6279483B2 (ja) 2018-02-14

Family

ID=51228598

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014546717A Expired - Fee Related JP6279483B2 (ja) 2011-12-13 2012-12-13 くも膜下出血および虚血の治療法
JP2017217549A Expired - Fee Related JP6741642B2 (ja) 2011-12-13 2017-11-10 くも膜下出血および虚血の治療法
JP2020085748A Pending JP2020128419A (ja) 2011-12-13 2020-05-15 くも膜下出血および虚血の治療法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017217549A Expired - Fee Related JP6741642B2 (ja) 2011-12-13 2017-11-10 くも膜下出血および虚血の治療法
JP2020085748A Pending JP2020128419A (ja) 2011-12-13 2020-05-15 くも膜下出血および虚血の治療法

Country Status (12)

Country Link
EP (1) EP2800575B1 (enExample)
JP (3) JP6279483B2 (enExample)
KR (2) KR102114490B1 (enExample)
CN (1) CN104053448B (enExample)
AU (1) AU2012354072B2 (enExample)
DK (1) DK2800575T3 (enExample)
ES (1) ES2731266T3 (enExample)
IL (1) IL233103B (enExample)
MX (1) MX364562B (enExample)
SG (2) SG10201604676WA (enExample)
WO (1) WO2013088382A1 (enExample)
ZA (1) ZA201404636B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2440230B1 (en) 2009-06-10 2020-11-11 NoNO Inc. Treatment regimes for treatment of neurological disease
PT2723363T (pt) 2011-06-24 2018-11-08 Nono Inc Terapia de combinação para isquemia
US9241970B2 (en) 2011-12-13 2016-01-26 Nono Inc. Therapy for subarachnoid hemorrhage and ischemia
JP6633523B2 (ja) * 2013-12-01 2020-01-22 ユニバーシティ オブ コペンハーゲン Psd−95の二量体阻害剤脂肪酸誘導体
SMT202000307T1 (it) 2014-05-28 2020-07-08 Nono Inc Sale cloruro di tat-nr2b9c
WO2017185250A1 (zh) * 2016-04-27 2017-11-02 拜西欧斯(北京)生物技术有限公司 兴奋性神经毒性相关损伤的治疗方法
CN107312071B (zh) * 2016-04-27 2018-11-06 拜西欧斯(北京)生物技术有限公司 兴奋性神经毒性相关损伤的治疗方法
CN109985047B (zh) * 2017-12-29 2021-07-27 广州市赛普特医药科技股份有限公司 5α-雄甾-3β,5,6β-三醇在制备治疗出血性脑卒中药物中的应用
CN109009111A (zh) * 2018-07-16 2018-12-18 重庆大学 低场核磁共振脑出血动态监护仪控制系统
CN113284126B (zh) * 2021-06-10 2022-06-24 安徽省立医院(中国科学技术大学附属第一医院) 人工神经网络图像分析预测脑积水分流手术疗效的方法
CN113735938B (zh) * 2021-07-30 2024-11-08 英纳氏(珠海)药业有限公司 一种神经保护多肽化合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7510824B2 (en) 1999-06-02 2009-03-31 Nono Inc. Method of screening peptides useful in treating traumatic injury to the brain or spinal cord
EP1884521A1 (en) * 2006-07-31 2008-02-06 Xigen S.A. Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins
DK2120987T3 (en) * 2007-03-02 2014-02-24 Nono Inc Treatment of stroke and other diseases without inhibiting N-type calcium channels
EP2440230B1 (en) * 2009-06-10 2020-11-11 NoNO Inc. Treatment regimes for treatment of neurological disease

Similar Documents

Publication Publication Date Title
JP7439187B2 (ja) 新しいボツリヌス毒素製剤の長期持続作用
CA2923685C (en) Application of r-ketamine and salt thereof as pharmaceuticals
Ge et al. LVIS stent versus enterprise stent for the treatment of unruptured intracranial aneurysms
HRP20210112T1 (hr) Režimi liječenja namijenjeni liječenju neurološke bolesti
HRP20231613T1 (hr) Pripravci koji sadrže sredstvo za unošenje i njihova priprava
TW201217343A (en) Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
CN109715151A (zh) 用于治疗癫痫性紊乱的方法和组合物
RU2015104492A (ru) Композиция для лечения гиперлипидемии, содержащая производное оксинтомодулина
JP2010532761A5 (enExample)
JP2015512406A5 (enExample)
JP7280619B2 (ja) ペプチド組成物
JP2017503014A5 (enExample)
WO2011144746A2 (en) Liquid nasal spray containing low-dose naltrexone
RU2017124487A (ru) НОВЫЙ ПЕПТИД-ИНГИБИТОР PI3Kγ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ОРГАНОВ ДЫХАНИЯ
FI3511004T3 (fi) Yhdistelmävalmisteita syövän hoitoon
AU2012289968B2 (en) Stable anti-inflammatory solutions for injection
CN103189078A (zh) 含有透明质酸和l-精氨酸的抗粘连剂
CA2596283A1 (en) Embolization using poly-4-hydroxybutyrate particles
JP2024502463A (ja) 治療指数を改善するためのプラスミン耐性ペプチド
JP2018507260A (ja) 鉄欠乏性貧血の治療におけるクエン酸第二鉄の使用
RS58543B2 (sr) Optimizovana farmaceutska formulacija za lečenje zapaljenskih promena ezofagusa
US20130337050A1 (en) Drug Transporter Permeating Blood-Brain Barrier, Peptide and Use Thereof
ES2694506T3 (es) Administración de ibuprofeno por vía intravenosa
RU2013108390A (ru) Фармацевтическая композиция для предотвращения периоперационной артериальной гипотензии у человека
ME02644B (me) Novi preparati alfentanila za tretman akutnog bola